fda warning letters compounded semaglutide september 2025 Article: Brazilian Clinics and the False Equivalence of GLP-1 Drugs: ANVISA should follow From Crackdown to Collaboration: FDA

The medical takeaway is simple: retatrutide is not just another celebrity weight-loss trend. It is part of a larger movement toward more powerful incretin-based therapies that may change how obesity, metabolic disease, and body composition are treated

But you may not notice a change to your appetite after your first dose, cautions Dr

Avoid injecting into broken skin, scar tissue, bruised or infected areas, moles, or sites showing signs of lipohypertrophy

Bioorg Med Chem 21:70647073 Druce MR, Minnion JS, Field BC et al (2009) Investigation of structure-activity relationships of Oxyntomodulin (Oxm) using Oxm analogs